| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $764.2M | +25.0% |
| Cost of Revenue | $232.3M | +24.0% |
| Gross Profit | $531.9M | +25.4% |
| R&D Expense | $76.3M | -5.5% |
| SG&A Expense | $498.5M | +10.7% |
| Operating Income | -$82.1M | +39.7% |
| Interest Expense | $45.9M | +84.6% |
| Pre-tax Income | -$143.4M | +11.5% |
| Income Tax | -$45K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $160.8M | +15.8% |
| Accounts Receivable | $97.3M | +17.3% |
| Inventory | $169.4M | -3.3% |
| Current Assets | $450.9M | +8.0% |
| Total Assets | $791.2M | +2.0% |
| Current Liabilities | $219.2M | +43.2% |
| Long-term Debt | $565.9M | -1.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.2M | +201.3% |
| Capital Expenditures | $42.5M | -49.0% |
| Investing Cash Flow | -$53.4M | +42.7% |
| Financing Cash Flow | $30.0M | -46.6% |
| Free Cash Flow | $2.8M | +102.2% |
| -190.0% |
| Net Income | -$143.4M | +11.6% |
| EPS (Basic) | -$0.96 | +15.0% |
| EPS (Diluted) | -$0.96 | +15.0% |
| Stockholders' Equity |
| $12.4M |
| +187.7% |